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SUMMARY 
Campylobacter jejuni, the leading cause of bacterial acute gastroenteritis worldwide, secretes 
an arsenal of virulence-associated proteins within outer membrane vesicles (OMVs). C. jejuni 
OMVs contain three serine proteases (HtrA, Cj0511 and Cj1365c) which cleave the intestinal 
epithelial cell (IEC) tight and adherens junction proteins occludin and E-cadherin, promoting 
enhanced C. jejuni adhesion to and invasion of IECs. C. jejuni OMVs also induce IECs innate 
immune responses. The bile salt sodium taurocholate (ST) is sensed as a host signal to co-
ordinate the activation of virulence-associated genes in the enteric pathogen Vibrio cholerae. 
In this study, the effect of ST on C. jejuni OMVs was investigated. Physiological 
concentrations of ST do not have an inhibitory effect on C. jejuni growth until the early 
stationary phase. Co-culture of C. jejuni with 0.1% or 0.2% (w/v) ST stimulates OMV 
production, increasing both lipid and protein concentrations. C. jejuni ST-OMVs possess 
increased proteolytic activity and exhibit a different protein profile compared to OMVs isolated 
in the absence of ST. ST-OMVs exhibit enhanced cytotoxicity and immunogenicity to T84 
IECs and enhanced killing of Galleria mellonella larvae. ST increases the level of mRNA 
transcripts of the OMVs-associated serine protease genes and the cdtABC operon that encodes 
the cytolethal distending toxin. Co-culture with ST significantly enhances the OMVs-induced 
cleavage of E-cadherin and occludin. C. jejuni OMVs also cleave the major endoplasmic 
reticulum (ER) chaperone protein BiP/GRP78 and this activity is associated with the Cj1365c 
protease. This data suggests that C. jejuni responds to the presence of physiological 
concentrations of the bile salt ST which increases OMV production and the synthesis of 
virulence-associated factors that are secreted within the OMVs. We propose that these events 
contribute to pathogenesis. 
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INTRODUCTION 
Campylobacter jejuni is a motile Gram-negative bacterium regarded as the leading cause of 
bacterial food-borne gastroenteritis worldwide (Kaakoush et al., 2015, Skarp et al., 2016). C. 
jejuni possesses multiple virulence factors, such as an O-linked glycosylated flagella 
(Wassenaar et al., 1991, Mertins et al., 2013), a polysaccharide capsule and lipo-
oligosaccharide (LOS) (Bacon et al., 2001, Maue et al., 2013), multiple adhesins (Monteville 
et al., 2003), a cytolethal distending toxin (CDT) (Johnson et al., 1988, Whitehouse et al., 
1998, Lara-Tejero et al., 2001) and multiple proteases (Brondsted et al., 2005, Karlyshev et 
al., 2014, Elmi et al., 2016). 
A defining feature of bacterial pathogens is the ability to sense host metabolites and precisely 
co-ordinate the expression of multiple virulence factors (Finlay et al., 1997, Fang et al., 2016a, 
Fang et al., 2016b, Olive et al., 2016). Bile is a well-characterised host metabolite, 
biosynthesised from cholesterol by hepatocytes in the liver (Joyce et al., 2016, Vitek et al., 
2016). Bile is excreted from the gall bladder into the small intestine, particularly in the 
duodenum, jejunum and proximal ileum. The physiological concentration of bile in the 
intestine can be as high as 20 mM in the duodenum, then progressively decreasing to 10 mM 
in the jejunum, reaching as little as 4 mM in the ileum (Hofmann et al., 2008, Maldonado-
Valderrama et al., 2011). In the intestine, bile emulsifies dietary fats and facilitates absorption 
of lipid nutrients. In addition, owing to the heterogeneous mixture of bile salts, bilirubin, 
phospholipids, cholesterol and enzymes, bile also has detergent-like toxicity and functions as 
a potent antimicrobial agent, solubilising membrane lipids including the dissociation of 
bacterial membrane proteins (Hofmann et al., 1967, Begley et al., 2005, Garidel et al., 2007, 
Boyer, 2013). For many enteric pathogens including Escherichia coli O157:H7, Vibrio 
cholerae, Shigella flexneri and Vibrio parahaemolyticus, bile acts as a signal to modulate 
global gene expression of virulence factors (Alam et al., 2010, Gotoh et al., 2010, Faherty et 
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al., 2012, Hamner et al., 2013, Bachmann et al., 2015, Sanchez et al., 2016, Sistrunk et al., 
2016). The conjugated bile salt sodium taurocholate (ST) has been shown to act as a host signal 
for the V. cholerae 7th pandemic O1 El Tor biotype strain N16961 (Yang et al., 2013), inducing 
intermolecular di-sulphide bond formation in the transmembrane transcription activator TcpP 
(Yang et al., 2013). More recently, the mechanisms by which V. parahaemolyticus senses bile 
salts via the type III secretion system 2 (T3SS2) regulators VtrA and VtrC have been identified 
(Li et al., 2016). Analysis of the crystal structure of the periplasmic domains of the VtrA/VtrC 
heterodimer revealed that VtrA and VtrC form a protein complex on the surface of the outer 
membrane creating a barrel-like structure that binds to bile salts and induces V. 
parahaemolyticus to secrete toxins (Li et al., 2016). 
As with the other Proteobacteria pathogens Haemophilus ducreyi, Aggregatibacter 
actinomycetemcomitans and Shigella dysenteriae, C. jejuni possesses CDT which interferes 
with normal cell cycle progression, resulting in G2 arrest (Pickett et al., 1996, Whitehouse et 
al., 1998, Purdy et al., 2000). CDT (encoded by the cdtABC operon) is the only identified toxin 
in C. jejuni, yet the role that host metabolites such as bile salts play in inducing CDT secretion 
is unclear. Like many other enteric pathogens, C. jejuni encounters bile salts during human 
infection (Drion et al., 1988, Raphael et al., 2005). The bile salt sodium deoxycholate induces 
differential expression of C. jejuni virulence genes, notably increasing the expression of 
Campylobacter Invasion Antigen (Cia) genes, leading to enhanced invasion of IECs by C. 
jejuni (Malik-Kale et al., 2008). However the effects of the taurocholate-conjugated 
hydrophilic bile salts such as ST on C. jejuni physiology or the role of ST as a host cellular 
signal for C. jejuni have not been previously investigated. 
Outer membrane vesicles (OMVs) are nano-sized structures (50 –250nm in diameter) that are 
released by all Gram-negative bacteria (Kulkarni et al., 2014, Schwechheimer et al., 2015). 
OMVs are enriched with an active molecular cargo of virulence factors such as adhesins, 
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invasins, toxins, proteases, antigenic proteins and non-protein antigens such as lipo-
polysaccharide (LPS). OMVs are associated with a multi-faceted role in bacterial pathogenesis 
(Schertzer et al., 2013, Kaparakis-Liaskos et al., 2015, Schwechheimer et al., 2015, Vanaja et 
al., 2016). So far only limited studies on the role of stress response pathways on bacteria 
vesiculation have been reported (McBroom et al., 2007, Macdonald et al., 2013, 
Schwechheimer et al., 2013a, Schwechheimer et al., 2013b, Schwechheimer et al., 2014). 
Whilst these studies have contributed to the understanding of the role of OMVs in bacterial 
pathophysiology, there are probably many roles of OMVs in bacterial pathogenesis that are 
still poorly defined. These questions are particularly relevant for understanding C. jejuni 
pathogenesis that in comparison to other enteric pathogens, is poorly understood. 
C. jejuni produces OMVs enriched with an active arsenal of virulence factors (Lindmark et al., 
2009, Elmi et al., 2012). More recently we have highlighted the role of three serine proteases 
(HtrA, Cj0511 and Cj1365c) secreted in C. jejuni OMVs which cleave the intestinal epithelial 
cell (IEC) tight and adherens junction proteins occludin and E-cadherin, promoting enhanced 
C. jejuni adhesion to and invasion of IECs (Elmi et al., 2016). The role of C. jejuni OMVs in 
pathogenesis and the emerging role of bile salts such as ST in inducing bacterial virulence led 
to the investigation of the effect of ST on C. jejuni OMVs production. ST stimulates C. jejuni 
11168H OMVs production, increasing both the protein concentration and lipid content of 
OMVs. ST enhances the proteolytic activity associated with C. jejuni OMVs, leading to 
enhanced OMVs cytotoxicity and immunogenicity to IECs. ST increases the level of mRNA 
transcripts of the OMVs-associated serine protease genes and also the cdtABC operon. 
Collectively, our data demonstrates that C. jejuni responds to physiological concentrations of 
the bile salt ST, increasing OMVs production and the synthesis of virulence-associated factors 
that are secreted within the OMVs. 
  
6 
 
RESULTS  
Co-culture with sodium taurocholate increases both the protein concentration and lipid 
content of C. jejuni OMVs 
As bile salts have bactericidal properties (Begley et al., 2005, Merritt et al., 2009), the effect 
of ST on the growth of C. jejuni was investigated. No significant difference in growth rate as 
measured by OD600 readings (Figure 1A) or CFU counts (Figure 1B) was observed when C. 
jejuni 11168H was cultured in Brucella broth in the presence of 0.1% or 0.2% (w/v) ST 
compared to bacteria cultured in Brucella broth alone. To investigate whether ST had any 
damaging effects on C. jejuni membranes, LIVE/DEAD BacLight staining was performed 
using microplate fluorescence and confocal microscopic analysis of C. jejuni 11168H after co-
culture in Brucella broth for 12 hours in the presence of 0.1% or 0.2% (w/v) ST. No reduction 
in the numbers of live C. jejuni cells was observed in the presence of ST (Figure 1C), indicating 
that the viability of C. jejuni cells were not affected by either of these concentrations of ST. 
Confocal microscopic analysis of C. jejuni 11168H also revealed the membrane integrity of 
the bacterial cells was not affected (Figure 1D). 
OMVs isolated from C. jejuni 11168H cultured in the presence of 0.1% or 0.2% (w/v) ST (ST-
OMVs) had significantly higher protein concentrations than OMVs isolated from the same 
volume of C. jejuni 11168H cultured in the absence of ST (Figure 2A). In addition, the lipid 
content of C. jejuni ST-OMVs was also increased compared to OMVs isolated from C. jejuni 
11168H cultured in the absence of ST (Figure 2B). To establish the role of ST in enhancing C. 
jejuni OMV formation, the amount of Keto-deoxy-d-manno-8-octanoic acid (Kdo) associated 
with OMVs was assessed. Kdo is a characteristic constituent of Gram-negative bacterial LPS 
and LOS (Brade et al., 1984). The amount of Kdo associated with OMVs isolated from C. 
jejuni 11168H cultured in the presence of 0.1% or 0.2% (w/v) ST was significantly increased 
(Figure 2C). To extend these findings, OMVs were separated on SDS-PAGE gel and stained 
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with silver stain to visualise LOS. The presence of 0.1% or 0.2% (w/v) ST resulted in enhanced 
staining of OMVs-associated LOS compared OMVs isolated in the absence of ST (Figure 2D). 
 
Proteomic analysis indicates an increase in the number of proteins associated with C. 
jejuni ST-OMVs 
To further investigate the significance of ST on C. jejuni OMV production, the proteome of 
OMVs isolated from C. jejuni 11168H grown in the presence of 0.2% (w/v) ST was 
investigated. A total of 185 proteins were identified (Table S1), 131 of which were also 
identified in our earlier proteomic analysis of C. jejuni 11168H OMVs (Elmi et al., 2012). The 
proportions of proteins from each cluster of orthologous groups (COG) categorization are 
shown in Figure 3. Of the 34 new proteins identified as specific to ST-OMVs, one of the 
Campylobacter invasion antigens CiaI (Cj1450) (Buelow et al., 2011) was identified as well 
as the Cj1365c protease and the bile salt response protein Cj0561c. Cj1614 and Cj0755, which 
are involved in the binding, uptake or export of trace metals, and the 2-oxoglutarate-acceptor 
oxidoreductase subunit OorABC were also identified along with Cj0628, a putative 
autotransporter protein that functions as an adhesin with a role in colonisation (Ashgar et al., 
2007). 
 
Co-culture with sodium taurocholate significantly enhances OMVs proteolytic activity 
C. jejuni 11168H OMVs contain biologically active serine proteases that interact with IEC 
proteins to enhance C. jejuni adherence to and invasion of IECs (Elmi et al., 2012, Elmi et al., 
2016). C. jejuni 11168H ST-OMVs exhibited a statistically significant enhanced proteolytic 
activity compared to OMVs isolated from C. jejuni 11168H cultured in the absence of ST 
(Figure 4). 
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ST-OMVs exhibit enhanced cytotoxicity and immunogenicity to T84 intestinal epithelial 
cells 
Given ST-OMVs exhibit enhanced proteolytic activity, the cytotoxicity of C. jejuni OMVs and 
ST-OMVs co-incubated with T84 IECs for 24 hours was investigated. Increased levels of 
cytosolic lactate dehydrogenase (LDH) after co-incubation of T84 IECs with ST-OMVs was 
observed compared to co-incubation with OMVs (Figure 5A). The induction of interleukin-8 
(IL-8) from T84 cells by OMVs and ST-OMVs was quantified using ELISA (enzyme-linked 
immunosorbent assay). ST-OMVs significantly enhanced induction of IL-8 compared to co-
incubation with OMVs (Figure 5B). The effect of ST on the OMV-induced up-regulation of 
IL-8 was also investigated. ST enhanced the mRNA transcription of IL-8 in T84 IECs (Figure 
5C). 
 
ST-OMVs exhibit enhanced cytotoxicity in the Galleria mellonella model of infection 
To investigate the effect of ST on C. jejuni OMVs in vivo, 11168H ST-OMVs and OMVs were 
injected into G. mellonella larvae. Injection with ST-OMVs resulted in an increase in killing 
of larvae compared to injection with OMVs (Figure 6). To investigate whether ST had any 
toxicity towards G. mellonella larvae, ST alone was also injected. No killing was observed in 
the G. mellonella larvae injected with 10 l of either 0.1% or 0.2% (w/v) ST. 
 
Co-culture with sodium taurocholate results in differential expression of genes encoding 
OMV-associated CDT and serine proteases 
The effects of ST on the relative expression of genes involved in C. jejuni cytotoxicity (cdtABC 
operon) and proteolytic activity (htrA, Cj0511 and Cj1365c) were investigated. Total RNA was 
isolated from C. jejuni 11168H cultured in the absence of ST or in the presence of 0.1% or 
0.2% (w/v) ST. Expression of both the cdtABC operon (Figure 7A) and the serine protease 
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genes (Figure 7B) was significantly enhanced relative to the level of the housekeeping DNA 
gyrase gene gyrA (Ritz et al., 2009). In agreement with the proteolytic and cytotoxicity data, 
these data imply that ST enhances the expression of C. jejuni 11168H virulence-associated 
genes to facilitate enhanced proteolytic activity, cytotoxicity and immunogenicity. 
 
Co-culture with sodium taurocholate significantly enhances the OMV-induced cleavage 
of occludin and E-cadherin in vitro 
C. jejuni OMVs cleave the major tight junction (TJ) and adheren junctions (AJ) proteins 
occludin and E-cadherin (Elmi et al., 2016). Recombinant occludin and E-cadherin were co-
incubated with OMVs and ST-OMVs. Incubation with ST-OMVs resulted in an increase in the 
cleaved form of both occludin and E-cadherin compared to incubation with OMVs (Figure 
8AB). 
 
C. jejuni 11168H OMVs cleave the major endoplasmic reticulum (ER) chaperone protein 
BiP/GRP78 
The Cj1365c protease possesses a subtilase domain. The amino acid sequences of the subtilase 
domain share 20% identity with the A subunit (SubA) of the subtilase cytotoxin SubAB of 
Shiga toxigenic Escherichia coli (STEC). STEC SubA mediates an unusual toxicity of the 
SubAB5 toxin with an extreme substrate specificity towards ER chaperone GRP78/BiP (Paton 
et al., 2006). Despite the low level of sequence identity, the position of the key residues in the 
catalytic serine active site of Cj1365c at position 274 (numbering corresponds to the protein 
without signal sequence) is conserved in STEC SubA, suggesting that GRP78/BiP may serve 
as a substrate for the Cj1365c protease. The activity of OMVs isolated from C. jejuni in the 
presence or absence of ST to cleave recombinant GRP78/BiP was therefore investigated. C. 
jejuni OMVs were able cleave GRP78/BiP and this cleavage was enhanced with ST-OMVs 
10 
 
(Figure 9A). OMVs isolated from the 11168H wild-type strain and from the three protease 
mutants (htrA, Cj0511 and Cj1365c) were co-incubated with recombinant GRP78/BiP. Only 
OMVs isolated from the Cj1365c mutant exhibited reduced ability to cleave GRP78/BiP 
(Figure 9B). 
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DISCUSSION 
C. jejuni OMVs are cytotoxic, immunogenic and proteolytic (Elmi et al., 2016). However the 
effect of host metabolites such as bile salts on C. jejuni OMVs secretion, content and function 
has not been studied. Recently genetic, biochemical and transcriptome analyses have been used 
to reveal the role of bile salts in inducing the pathogenesis of different enteric bacteria (Joyce 
et al., 2016, Sistrunk et al., 2016). Bile salts mediate reciprocal host-pathogen crosstalk (Gotoh 
et al., 2010, Chaand et al., 2013) and there is increasing evidence supporting the role of bile 
salts in regulating bacterial virulence gene expression (Yang et al., 2013, Li et al., 2016, Xue 
et al., 2016). ST plays an important role in inducing V. cholerae virulence gene expression 
(Xue et al., 2016), However the effect of ST on C. jejuni has not been investigated. In this 
study, we have characterised the role of ST in modulating C. jejuni 11168H OMVs secretion, 
content and function. Both the protein and lipid concentration of 11168H OMVs were 
increased when C. jejuni was cultured in the presence of physiologically relevant 
concentrations of ST (0.1% and 0.2% w/v ST). Changes in OMV secretion, content and 
function under various growth conditions have also been observed in a number of other 
bacterial pathogens (Tashiro et al., 2010, Choi et al., 2014, Metruccio et al., 2016). 
Proteomic analysis of C. jejuni 11168H ST-OMVs identified all 131 proteins previously 
identified associated with 11168H OMVs (Elmi et al., 2012), but also a further 34 proteins, 
including proteins expected to be involved C. jejuni response to bile salts such as Cj0561c for 
efficient colonisation (Guo et al., 2008). The presence of CiaI (Cj1450) was of note as this is 
the first time that one of the Cia proteins has been identified associated with OMVs. Previously 
the secretion mechanism of CiaI via the flagellum was shown to be independent of host cell 
contact (Barrero-Tobon et al., 2014). During colonisation of the human intestine, C. jejuni will 
be exposed to a number of different bile salts. The bile salt sodium deoxycholate (SD) increases 
the expression of cia genes (Malik-Kale et al., 2008), however the effect of ST on cia gene 
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expression has not been investigated. It is possible that a combination of SD and ST would 
increase the number of Cia proteins that could be identified associated with C. jejuni OMVs. 
Secretion of Cia proteins within OMVs would provide a new mechanism for the delivery of 
these virulence determinants into host cells. 
The three proteases (HtrA, Cj0511 or Cj1365c) associated with OMVs are conserved in C. 
jejuni and inactivation of each has been linked to the attenuation of C. jejuni physiology, 
virulence and/or immunogenicity (Brondsted et al., 2005, Karlyshev et al., 2014, Jowiya et al., 
2015). The enhanced proteolytic activity of 11168H ST-OMVs indirectly indicates a more 
pathogenic C. jejuni response during colonisation of a host after the bacteria senses bile salts. 
The cytotoxic and immunogenic properties of OMVs are well characterised (Kaparakis-
Liaskos et al., 2015, Pathirana et al., 2016). The enhanced cytotoxicity and immunogenicity of 
ST-OMVs may be associated with the increase in concentrations of proteases and CDT secreted 
in ST-OMVs, based on the qPCR analysis which showed that ST significantly up-regulates 
expression of htrA, Cj0511, Cj1365 and the cdtABC operon. This supports an emerging 
consensus that bile salts in the intestine play important roles in modulating bacterial gene 
expression. The enhanced expression of cdtA is consistent with the dynamics of operon 
expression with a recent study reporting that there is a linear relationship between transcription 
distance and gene expression in operons (Lim et al., 2011). This observation also indicates the 
importance of CdtA and CdtC which are involved in delivery of CdtB which possesses type I 
deoxyribonuclease-like activity that mediates IECs DNA damage, triggering the response of 
the cell cycle checkpoint and results in G2 arrest (Lara-Tejero et al., 2001). Internalisation of 
CdtB is also positively correlated with CdtA and CdtC as purified CdtB alone has no effect on 
IECs, but when combined with CdtA and CdtC, IECs exhibited cell cycle arrest in the G2/M 
phase (Elwell et al., 2001, Lara-Tejero et al., 2001). However in contrast to Vibrio species, the 
mechanism(s) of ST interactions with C. jejuni remains unclear. C. jejuni lacks orthologues of 
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V. parahaemolyticus VtrA and VtrC that create a barrel-like structure that can bind to bile salts 
and trigger the production of cholera toxin. ST might cause changes in C. jejuni outer 
membrane proteins or alter levels and/or activities of yet unidentified C. jejuni proteins that 
could regulate synthesis and protein folding machinery or post-translational modifications. C. 
jejuni has orthologues of the Maintenance of lipid asymmetry (Mla) pathway proteins which 
retrograde phospholipid transport from the OM back to the IM and are involved in bacterial 
OMVs biogenesis in V. cholerae and Haemophilus influenzae (Roier et al., 2016a, Roier et al., 
2016b). However further studies are required to identify the precise mechanism of C. jejuni 
ST-induced OMV biosynthesis.  
ST-OMVs enhanced the cleavage of both occludin and E-cadherin and this was more 
pronounced for occludin than for E-cadherin. One explanation is that C. jejuni may 
preferentially bind and cleave apically located tight junction proteins such as occludin that 
function to seal the paracellular passage that is crucial for IEC integrity. C. jejuni also invades 
IECs via an actin filament-mediated mechanism and actin filaments interface with tight 
junction proteins (Biswas et al., 2003). In addition, this result reinforces previous findings that 
correlated significant decrease in transepithelial electrical resistance (TEER) with 
redistribution and dephosphorylation of occludin instead of E-cadherin (Chen et al., 2006). 
Loss of occludin in IECs infected with C. jejuni also led to significant alteration in tight 
junction transmembrane proteins (MacCallum et al., 2005). Similar studies in Escherichia coli 
(EPEC) and Salmonella enterica serovar Typhimurium also showed a pathogenic mechanism 
associated with occludin-specific redistribution (Sakakibara et al., 1997, McNamara et al., 
2001, Bertelsen et al., 2004). It appears that a number of virulence-associated serine proteases 
secreted by different enteric pathogens preferentially alter the expression and distribution of 
occludin, indicating that occludin might be an important IEC target that shapes the bacterial-
host interplay (Guttman et al., 2008, Awad et al., 2017, Eichner et al., 2017). Future studies 
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should focus on understanding the precise mechanisms of OMV-associated serine proteases 
that enteric pathogens including C. jejuni use to interact with and cleave/modify occludin. 
The ER chaperone GRP78/BiP protein is highly conserved and essential for the survival of 
eukaryotic cells. GRP78/BiP also maintains the permeability barrier of the ER membrane and 
plays a crucial role in the unfolded-protein response (UPR) as the ER stress-signalling master 
regulator. For the first time C. jejuni OMVs have also been shown to cleave the recombinant 
ER chaperone GRP78/BiP, a key cellular target for AB5 toxins (Paton et al., 2006, Beddoe et 
al., 2010, Paton et al., 2010). This activity was only reduced in OMVs isolated from a Cj1365c 
mutant, suggesting that it is this protease responsible for the cleavage of GRP78/BiP. Cj1365c 
is a multi-domain protein, containing an autotransporter domain as well as a subtilisin-like 
serine domain. Serine proteases belonging to the family of subtilisin-like proteases are secreted 
by a wide variety of bacterial pathogens and have been shown to cleave host proteins including 
immunoglobulins, complement compounds and proteins of the extracellular matrix (Male, 
1979, Juarez et al., 1999, Mortensen et al., 2011). Considering previous studies have suggested 
that the expression of CDT is not directly linked to C. jejuni disease severity (Abuoun et al., 
2005, Mortensen et al., 2011), this observation may also highlight the importance of the 
Cj1365c protease in C. jejuni pathogenesis. The Cj1365c protease has previously been 
suggested to be one of the C. jejuni virulence factors associated with the development of bloody 
diarrhoea, independent of pVir plasmid (Louwen et al., 2006). The novel AB5 toxin that cleaves 
GRP78/BiP also occurs in the loss of enterocyte effacement negative STEC O113:H21 
outbreak strain (Newton et al., 2009). 
In summary, ST is important not only for the up-regulation of the genes encoding HtrA, 
Cj0511, Cj1365c and CDT in vitro, but also for the modulation of C. jejuni OMV secretion, 
content and function. Our findings and other recent reports also highlight the importance of ST 
in inducing bacterial virulence. Enhanced C. jejuni vesiculisation induced by ST can also be 
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linked to enhanced cytotoxicity to both IECs and Galleria mellonella larvae as well as 
enhanced immunogenicity and proteolytic activity. This data suggests that C. jejuni responds 
to the presence of the bile salt ST by increasing OMV production and changing the protein 
content of OMVs to enhance pathogenesis. 
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EXPERIMENTAL PROCEDURES 
 
Bacterial strains and culture conditions 
 
The C. jejuni wild-type strain used in this study was 11168H, a hypermotile derivative of the 
sequence strain NCTC11168 that shows higher levels of caecal colonisation in a chick 
colonisation model (Jones et al., 2004). C. jejuni strains were grown either on blood agar plates 
containing Columbia agar base (Oxoid, UK) supplemented with 7% (v/v) horse blood (TCS 
Microbiology, UK) and Campylobacter Selective Supplement (Oxoid) or in Brucella broth 
(Oxoid) with shaking at 75 rpm in a microaerobic chamber (Don Whitley Scientific, UK) 
containing 85% N2, 10% CO2 and 5% O2 at 37°C. Kanamycin (Sigma-Aldrich, UK) was added 
to blood agar plates or to Brucella broth as required at the concentration of 50 μg/ml. Unless 
otherwise stated, C. jejuni strains were grown on blood agar plates for 24 h prior to use in all 
subsequent experiments. 
 
Isolation and Quantification of C. jejuni OMVs 
 
C. jejuni OMVs were isolated as described previously (Elmi et al., 2012). C. jejuni from a 24 h 
blood agar plate were resuspended in 1 ml Brucella broth and used to inoculate 100 ml pre-
equilibrated Brucella broth to an OD600 of 0.1. Cultures were grown for 12 h (OD600  1.2) then 
centrifuged at 4,000 x g for 30 mins at 4°C. The resulting supernatant was filtered through a 
0.22 µm membrane (Millipore, UK) then the filtrate concentrated to 2 ml using an Ultra-4 
Centrifugal Filter Unit with a nominal 10 kDa cutoff (Millipore). The concentrated filtrate was 
ultra-centrifuged at 150,000 x g for 3 h at 4°C using a TLA 100.4 rotor (Beckman Instruments, 
USA). All isolation steps were performed at 4°C and the resulting OMVs pellet was 
resuspended in phosphate buffered saline (PBS) and stored at -20°C. OMVs samples were 
plated out on blood agar plates and incubated under both microaerobic and aerobic conditions 
for 72 h to confirm the absence of viable bacteria. The protein concentration of the OMVs was 
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quantified using a bicinchoninic-acid assay (BCA Protein Assay; Thermo Fisher Scientific, 
UK) using BSA as the protein standard. 10 μg of each OMVs sample, based on protein 
concentration, was analysed using SDS-PAGE and stained using Silver stain Reagent (Thermo 
Fisher Scientific). The LOS profiles of the OMVs were examined using standard methods 
(Naito et al., 2010). The OMVs samples were separated on 12% (w/v) sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) gels and then visualised using silver staining.  
 
Further quantification of OMVs 
 
Further OMV quantification was performed as described previously (Lee et al., 1999) by 
measuring keto-deoxy-d-manno-8-octanoic acid (Kdo) content. Keto-deoxy-d-manno-8-
octanoic acid from E. coli LPS (Sigma-Aldrich) was used as the standard. For the quantification 
of the lipid content of OMVs, the fluorescent lipophilic dye FM4-64 (Thermo Fisher Scientific) 
was used to a final concentration of 5 μg/ml (McBroom et al., 2006). OMVs alone and the 
FM4-64 probe alone were used as negative controls.  
 
Mass spectrometry analysis 
 
Proteins from three separate C. jejuni OMVs preparations were resolved on SDS-PAGE gels 
then submitted to the Moredun Proteomics Facility for analysis. Each gel lane was excised and 
sliced horizontally from top to bottom to yield equal gel slices 2.5 mm deep. Each of the 
resulting gel slices was then subjected to standard in-gel destaining, reduction, alkylation and 
trypsinolysis procedures (Shevchenko et al., 1996). Digests were transferred to low-protein-
binding HPLC sample vials immediately prior to liquid chromatography-electrospray 
ionisation-tandem mass spectrometry (LC-ESI-MS/MS) analysis. Liquid chromatography was 
performed using a Dionex Ultimate 3000 nano-HPLC system (Thermo Fisher Scientific) 
comprising a WPS-3000 well-plate micro auto sampler, a FLM-3000 flow manager and column 
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compartment, a UVD-3000 UV detector, a LPG-3600 dual-gradient micropump and a SRD-
3600 solvent rack controlled by Chromeleon™ chromatography software 
(www.thermoscientific.com/dionex). A micro-pump flow rate of 246 µl/min was used in 
combination with a cap-flow splitter cartridge, affording a 1/82 flow split and a final flow rate 
of 3 µl/min through a 5 cm x 200 m ID monolithic reversed phase column (Thermo Fisher 
Scientific) maintained at 50C. Samples of 4 l were applied to the column by direct injection. 
Peptides were eluted by the application of a 15 min linear gradient from 8-45% solvent B (80% 
acetonitrile (Rathburn Chemicals, UK), 0.1% v/v formic acid) and directed through a 3 nl UV 
detector flow cell. LC was interfaced directly with a 3-D high capacity ion trap mass 
spectrometer (amaZon-ETD, Bruker Daltonics, Germany) via a low-volume (50 l/min 
maximum) stainless steel nebuliser (Agilent Technologies, UK / G1946-20260) and ESI. 
Parameters for tandem MS analysis were based on those described previously (Batycka et al., 
2006).  
 
Database mining 
Deconvoluted MS/MS data in mgf (Mascot Generic Format) format was imported into 
ProteinScape™ V3.1 (Bruker Daltonics) proteomics data analysis software for downstream 
mining of databases utilising the Mascot™ V2.4.1 (Matrix Science, UK) search algorithm. The 
protein content of each individual gel slice was established using the “Protein Search” feature 
of ProteinScape™, whilst separate compilations of the proteins contained in all gel slices for 
each sample were produced using the “Protein Extractor” feature of the software. Mascot 
search parameters were set in accordance with published guidelines (Taylor et al., 2005) using 
fixed (carbamidomethyl “C”) and variable (oxidation “M” and deamidation “N,Q”) 
modifications along with peptide (MS) and secondary fragmentation (MS/MS) tolerance values 
of 0.5 Da and allowing for a single 13C isotope. Molecular weight search (MOWSE) scores 
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attained for individual protein identifications were inspected manually and considered 
significant only if a) two peptides were matched for each protein, with each matched peptide 
containing an unbroken “b” or “y” ion series represented by of a minimum of four contiguous 
amino acid residues or b) one peptide was matched for each protein, containing an unbroken 
“b” or “y” ion series represented by of a minimum of eight contiguous amino acid residues.  
Files were searched with MASCOT software against C. jejuni NCTC 11168 protein databases 
derived from genomic sequence available at NCBI (Genbank, AL111168) 
(http://www.ncbi.nlm.nih.gov/).  
The NCTC 11168 annotated genome sequence indicates Clusters of Orthologous Group (COG) 
assignments (Tatusov et al., 1997) which were used to predict functional classification. 
Additionally the Basic Local Alignment Search Tool (BLAST) (Altschul et al., 1990), 
InterProScan (http://www.ebi.ac.uk/interpro/search/sequence-search) and The Koyoto 
Encyclopedia of Genes and Genomes (KEGG) (http://www.genome.jp/kegg/) (Kanehisa et al., 
2000) were used to investigate protein function. 
 
Quantitative determination of OMVs proteolytic activity 
 
The proteolytic activity of OMVs was determined using a Protease Fluorescent Detection Kit 
(Sigma-Aldrich) using a FITC-labelled casein substrate as described previously (Elmi et al., 
2016). OMVs (10 µg in 10 µl, based on protein concentration) from C. jejuni cultured in 
Brucella broth in the presence or absence of 0.1% or 0.2% (w/v) ST were mixed with 20 µl 
incubation buffer and 20 µl substrate then incubated at 37°C in the dark for 24 h. The reaction 
was stopped by adding 200 µl 0.6 N trichloroacetic acid to precipitate any remaining substrate, 
which was removed by centrifugation at 10,000 x g for 10 mins at 4°C. The supernatant 
obtained (10 µl) was diluted in 1 ml assay buffer. The digested FITC-casein substrate has 
absorption / emission maxima at 485 nm / 535 nm, and fluorescence intensity was recorded 
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using a Multi-Mode Microplate reader (Molecular Devices, UK). Bovine trypsin (1 µg/ml) was 
used as positive control in all experiments. 
 
Cell lines, media and culture conditions 
 
The human T84 colon cancer epithelial cells were obtained from the National Type Culture 
Collection. T84 cells were maintained at sub-confluence in DMEM / F-12 (Invitrogen, UK) 
supplemented with 10% (v/v) FCS, 1% (v/v) non-essential amino acids and 1% (v/v) penicillin-
streptomycin (Sigma-Aldrich) at 37°C in a 5% CO2 humidified atmosphere. Cells were split 
around 80-90% confluence and seeded at 5 x 106 cells per well into 24-well tissue culture plates 
(Corning Glass Works, Netherlands) using 1 ml volumes of cell culture media per well. 
Medium was replenished every 2 days. For ELISA experiments, the medium was removed and 
monolayers washed three times with PBS, then maintained in antibiotic-free medium 
supplemented with 10% (v/v) serum (Invitrogen) for 24 h before each experiment. 
 
Cytotoxicity detection assay 
 
The CytoTox 96® non-radioactive cytotoxicity assay (Promega, UK) was used to quantify the 
cell damage induced by co-culture T84 cells with OMVs isolated from C. jejuni cultured in 
Brucella broth in the presence or absence of 0.1% or 0.2% (w/v) ST. Briefly, T84 cells were 
challenged with 100 µg OMVs based on protein concentration. After co-incubation at 37°C for 
24 h, cell supernatants were analysed for the release of lactate dehydrogenase (LDH). Non-
challenged cells represented the 0% cytotoxicity negative control. Total lysis of cells following 
treatment with 1% (v/v) Triton X-100 represented the 100% cytotoxicity positive control. 
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Enzyme-linked immunosorbent assay (ELISA) for IL-8 quantitation 
 
T84 cells were co-cultured with 100 µg or 10 µg of OMVs based on protein concentration 
isolated from C. jejuni cultured in Brucella broth in the presence or absence of 0.1% or 0.2% 
(w/v) ST for 24 h. The levels of IL-8 secretion were assessed using a commercially available 
sandwich ELISA kit according to manufacturer’s instructions (E-Biosciences, UK). Detection 
was performed using a Dynex MRX II 96 well plate reader (Dynex, U.S.A) at an absorbance 
of 450 nm (A450) and analysed using Revelation software (Dynex). 
 
Galleria mellonella larvae model of infection 
 
G. mellonella larvae (LiveFoods Direct, UK) were kept on wood chips at 16°C. Experiments 
were performed with slight modifications from the original published methodology (Champion 
et al., 2010) as described previously (Gundogdu et al., 2011). Briefly, 5 µg of OMVs based on 
protein concentration isolated from C. jejuni cultured in Brucella broth in the presence or 
absence of 0.1% or 0.2% (w/v) ST, in a 10 µl volume were injected into the right foremost leg 
of the G. mellonella larvae by micro-injection (Hamilton, Switzerland). For each experiment, 
10 G. mellonella larvae were injected and experiments were repeated three times using larvae 
of the same approximate weight. Controls were both non-injected larvae or larvae injected with 
10 µl of sterile PBS. Larvae were incubated at 37°C and survival recorded at 24 h intervals for 
72 h. 
 
Quantitative real-time polymerase chain reaction (qRT-PCR).  
 
For measurements of gene expression, total RNA from either C. jejuni cultured in Brucella 
broth in the presence or absence of 0.1% or 0.2% (w/v) ST or T84 cells was extracted with 
Qiagen RNAeasy mini kit (Life Technologies). DNA contamination was removed with DNA-
free treatment (Ambion). The purified RNA was quantified using a Nanodrop machine 
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(NanoDrop Technologies, UK). Complementary DNA (cDNA) was synthesised with a 
Superscript III first-strand synthesis system (Life Technologies) according to the 
manufacturer's protocol. Briefly, 2 µg total RNA was used for the reverse-transcription reaction 
mixture (Fisher Scientific) using either random hexamers or oligo(dT) primers. Quantitative 
real-time PCR reactions were performed in triplicate using SYBR green master mix (Applied 
Biosystems) with ABI7500 machine (Applied Biosystems). Relative gene expression 
comparisons were performed using ΔΔCT method (Schmittgen et al., 2008), (where CT is 
threshold cycle) normalising the mean cycle threshold of each gene to the gyrA gene, which is 
considered a stably expressed housekeeping gene (Ritz et al., 2009). Primer efficiencies were 
tested with genomic DNA dilution series and primer sequences are listed in Table 1. 
 
in vitro cleavage of occludin and E-cadherin by C. jejuni OMVs 
 
The cleavage of recombinant TJ or AJ proteins (occludin or E-cadherin respectively) by OMVs 
was determined as described previously (Baek et al., 2011, Elmi et al., 2016). Briefly, OMVs 
(10 µg based on protein concentration) from C. jejuni cultured in Brucella broth in the presence 
or absence of 0.1% or 0.2% (w/v) ST were incubated with 1 µg recombinant human occludin 
or E-cadherin (R&D Systems, UK) in PBS at 37°C for 16 h. For analysis of occludin or E-
cadherin cleavage, reactions were mixed with 2X sample loading buffer (125 mM Tris-HCl 
(pH 6.8), 2% (w/v) SDS, 10% (v/v) 14.3 M β-mercaptoethanol, 10% (v/v) glycerol, 0.006% 
(w/v) bromophenol blue) and boiled for 10 min. Proteins were separated using 12% (w/v) 
Bis/Tris precast gels (Invitrogen) then transferred to nitrocellulose using an iBlot gel transfer 
device (Life Technologies). Membranes were incubated in a blocking buffer (2% (w/v) 
skimmed milk (Tesco, UK) in PBS) for 1 h at room temperature. After removal of blocking 
buffer, membranes were rinsed three times with 0.1% (v/v) Tween-20 in PBS then incubated 
1 h at room temperature with primary rabbit anti-occludin or primary mouse anti-E-Cadherin 
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or (Abcam, UK) (1:1,000). Following primary antibody incubation, membranes were washed 
four times with 0.1% (v/v) Tween-20 in PBS followed by incubation with an infrared 
fluorescence-conjugated secondary antibody (either goat anti-mouse IR800 or goat anti-rabbit 
IR680 (Licor Biosciences, UK) prepared in a 1:10,000 dilution of blocking buffer) at room 
temperature for 1 h. Membranes were scanned and analysed using a Licor Odyssey® (Licor 
Biosciences).  
 
in vitro cleavage of GRP78/BiP  
 
C. jejuni OMVs cleavage of GRP78/BiP was performed as previously described (Nagasawa et 
al., 2014). Briefly, 20 µg of OMVs based on protein concentration were incubated with PBS 
buffer with GRP78/BiP (Fisher Scientific) in a final volume of 25 µl at 37°C for 16 h. The 
reactions were stopped by addition of 2X sample loading buffer. The samples were analysed 
by SDS-PAGE and western blot as described above using GRP78/BiP primary antibody. 
 
Statistical analysis 
All experiments represent at least three biological replicates with each experiment performed 
in triplicate. All data were analysed using Prism statistical software (Version 6, GraphPad 
Software, USA). Values were expressed as mean ± SEM. Variables were compared for 
significance using Two-Way Analysis of Variance (ANOVA) and the Bonferroni test with one 
asterisk (*) indicating a p value between 0.01 and 0.05, two asterisks (**) indicating a p value 
between 0.001 and 0.01 and three asterisks (***) indicating a p value < 0.001. 
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TABLES 
Table 1. qRT-PCR primers used in this study.  
Gene name  Sequence 5’-3’ Melting Temp (°C) Source 
Cj1365cF GGTGTAGCCGATGATGCTTT 55.4 This study 
Cj1365cR GCCCCATAAGCCACTCCATA  56 This study 
Cj0511F TGGTGGAAGTGCTAGTGCAA 55.7 This study 
Cj0511R GGTTTTACACCCACTGCTTG 54.2 This study 
Cj1228cF TGATTGATGGTTTGAGTTTGAGA
A 
52.9 This study 
Cj1228cR TTCACTTTGTCCAACACCTATG 53 This study 
cdtAF TAGCGGTGCTGATTTAGTACCT 55.6 This study 
cdtAR CATCGCCAAATCCTTTGCTATCG 56.6 This study 
cdtBF GAACAGCCACTCCAACAGGACG 60.3 This study 
cdtBR CGATTAGCTCCTACATCAACG 
CGA 
58.6 This study 
cdtCF GCCTTTGCAACTCCTACTGGAG
AT 
56.9 This study 
cdtCR GCTCCAAAGGTTCCATCTTCTAA
G 
55.5 This study 
gryAF CCCACTTGCTAAAGTGCGTGA 54.6 This study 
gyrAR CCTTACCACCTCTGCTTTGC 55.5 This study 
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FIGURE LEGENDS 
Figure 1. ST does not affect the growth or outer membrane integrity of C. jejuni 11168H 
wild‐type strain. 
Growth curves of C. jejuni 11168H cultured in Brucella broth without ST or Brucella broth 
supplemented with 0.1% (w/v) ST or 0.2% ST (w/v) quantified by (A) OD600 or (B) Colony 
Forming Units (CFU). (C) Quantitative analysis of C. jejuni 11168H stained with LIVE/DEAD 
BacLight for the purpose of evaluating outer membrane integrity phenotype. (D) 
Representative fluorescence confocal images showing the relative live/dead cells of C. jejuni 
11168H cultured without ST or with 0.1% (w/v) or 0.2% (w/v) ST. Cells were stained with 
LIVE/DEAD BacLight (Life Technologies) (green = viable cells, red = dead cells). Scale bar, 
10 μm. 
 
Figure 2. ST increases the protein concentration of OMVs from C. jejuni 11168H wild‐
type strain. 
Quantification of the increase in OMVs isolated from C. jejuni 11168H in Brucella broth 
supplemented with 0.1% (w/v) or 0.2% (w/v) ST compared to without ST. The OD600 of ST 
treated 11168H cultures were normalised to the OD600 of untreated 11168H cultures for each 
OMV isolation. (A) BCA assay to determine protein concentration of OMVs. *, P < 0.05; ****, 
P < 0.0001. (B) Relative fold increase of OMVs determined using FM4-64 dye. *, P < 0.05; 
****, P < 0.0001. (C) Relative fold increase of OMVs determined using 3-deoxy-d-manno-
octulosonic acid (Kdo). ****, P < 0.0001. (D) LOS levels associated with OMVs as indicated 
by silver staining following separation by SDS-PAGE. 
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Figure 3. Proteomic analysis of ST-OMVs.  
 
Major protein functional categories (COGs) identified in C. jejuni 11168H ST-OMVs 
following proteomic analysis. 
 
Figure 4. Increased proteolytic activity of ST-OMVs. 
 
Quantification of proteolytic activity of OMVs isolated from 11168H cultured without ST or 
with 0.1% (w/v) or 0.2% (w/v) ST. FITC labelled casein was incubated with OMVs for 24 hr 
and OMV proteolytic activity assessed. **, P < 0.01; ****, P < 0.0001.  
 
Figure 5. Increased cytotoxic activity and immunogenicity of ST-OMVs. 
 
(A) Cytotoxic effect of OMVs isolated from 11168H in Brucella broth without ST or 
supplemented with 0.1% (w/v) or 0.2% (w/v) ST on T84 IECs after 24 hr co-incubation. The 
cytotoxic effect on the T84 cells was measured by quantifying the release of cytosolic lactate 
dehydrogenase (LDH) as a measure of cell damage. Non-challenged T84 cells represented 0% 
cytotoxicity (Uninfected Cells), and total lysis of T84 cells following treatment with 1% (v/v) 
Triton X-100 represented 100% cytotoxicity (Positive control). ***, P < 0.001. (B) 
Immunogenic effect of OMVs isolated from 11168H in Brucella broth without ST or 
supplemented with 0.1% (w/v) or 0.2% (w/v) ST on T84 IECs after 24 hr co-incubation. Levels 
of IL-8 secreted during C. jejuni OMV interactions with T84 cells were quantified using a 
human IL-8 ELISA. (C) Relative transcript levels of IL-8 in T84 cells co-incubated with OMVs 
from 11168H cultured without ST or supplemented with 0.1% (w/v) or 0.2% (w/v) ST. Relative 
transcript levels of GAPDH was used as an internal control. 
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Figure 6. ST enhances the cytotoxicity of C. jejuni OMVs in the Galleria mellonella 
infection model.  
G. mellonella larvae were injected with a 10 μl inoculum of OMVs (5 μg) from 11168H 
cultured in either Brucella broth without ST or supplemented with 0.1% (w/v) or 0.2% (w/v) 
ST. Larvae were incubated at 37°C, with survival and appearance recorded every 24 h. PBS 
and no-injection controls were used. For each experiment, 10 G. mellonella larvae were 
infected and experiments were repeated in triplicate. *, P < 0.05. 
 
Figure 7. qRT-PCR analysis of transcription in C. jejuni 11168H wild-type strain co-
incubated with ST.  
Quantitative real-time-PCR (qRT-PCR) analysis was performed using cdtA, cdtB, cdtC, 
Cj0511, Cj1365c and htrA transcript-specific primers. gyrA mRNA was used as an internal 
control. (A) The relative expression of cdtA, cdtB, cdtC. (B) The relative expression of Cj0511, 
Cj1365c and htrA. *, P < 0.05; **, P < 0.01; ***, P < 0.001. 
 
Figure 8. Increased cleavage by ST-OMVs of Occludin and E-cadherin.  
Recombinant Occludin or E-Cadherin were incubated with 10 μg of OMVs isolated from 
11168H cultured in Brucella broth without ST or supplemented with 0.1% (w/v) or 0.2% (w/v) 
ST. Reaction mixtures were stopped and aliquots separated by SDS-PAGE and immunoblotted 
with antibodies against (A) Occludin or (B) E-Cadherin. Arrows indicate putative cleaved 
band. The negative control with phosphate buffered saline showed no detectable cleavage 
product. 
 
Figure 9. Increased cleavage by ST-OMVs of GRP78/BiP. 
 
(A) Recombinant GRP78 was incubated with 20 μg of OMVs isolated from 11168H cultured 
in Brucella broth without ST or supplemented with 0.1% (w/v) or 0.2% (w/v) ST. Reaction 
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mixtures were stopped, aliquots separated by SDS-PAGE and immunoblotted with a GRP78 
antibody. Arrows indicate putative cleaved band. The negative control with phosphate buffered 
saline showed no detectable cleavage product. (B) Recombinant GRP78 was incubated with 
20 μg of OMVs isolated from either htrA, Cj0511 or Cj1365c mutants cultured in Brucella 
broth and compared to 11168H OMVs as above. 
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